CYP2C19 genotype has prognostic value in specific populations following coronary stenting

BACKGROUND: The prognostic value of the CYP2C19 genotype in post-percutaneous coronary intervention (PCI) patients remains controversial. The recently-published, limited-sample PHARMCLO trial indicates a personalized pharmacogenomic approach may reduce adverse events. This study aimed to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenyao, Shao, Chunli, Xu, Bo, Wang, Jingjia, Yang, Min, Chen, Jing, Zhang, Kuo, Wang, Siyuan, Li, Ping, Tang, Yi-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339845/
https://www.ncbi.nlm.nih.gov/pubmed/34422978
http://dx.doi.org/10.21037/atm-20-7724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339845/
https://www.ncbi.nlm.nih.gov/pubmed/34422978
http://dx.doi.org/10.21037/atm-20-7724

Ejemplares similares